Gilhus N E, Pandey J P, Gaarder P I, Aarli J A
Department of Neurology, University of Bergen, Norway.
J Autoimmun. 1990 Jun;3(3):299-305. doi: 10.1016/0896-8411(90)90148-l.
Gm and Km allotypes were examined in 29 myasthenia gravis patients with a thymoma and non-receptor skeletal muscle antibodies. The frequency of the phenotype Gm1,2,3;23;5,21 was significantly higher in the patients than in 292 healthy controls (P less than 0.01). Km allotype frequencies did not differ in patients and controls.
对29例患有胸腺瘤且伴有非受体骨骼肌抗体的重症肌无力患者进行了Gm和Km同种异型检测。患者中Gm1,2,3;23;5,21表型的频率显著高于292名健康对照者(P<0.01)。患者和对照者的Km同种异型频率无差异。